Company Filing History:
1 out of 155 
1 out of 237 Years Active: 2016-2019
Title: Constance Auvynet: Innovator in CCR2 Antagonist Peptides
Introduction
Constance Auvynet is a prominent inventor based in Paris, France. She has made significant contributions to the field of biochemistry, particularly in the development of peptides that serve as CCR2 antagonists. With a total of two patents to her name, Auvynet's work is paving the way for advancements in therapeutic applications.
Latest Patents
Auvynet's latest patents focus on CCR2 antagonist peptides. The first patent describes a peptide that functions as a CCR2 non-competitive antagonist. The second patent details a peptide comprising the amino acid sequence Thr-Phe-Leu-Lys (SEQ ID NO: 17) or Thr-Phe-Leu-Lys-Cys (SEQ ID NO: 1), which is also useful as a CCR2 non-competitive antagonist peptide. These innovations hold promise for future medical treatments.
Career Highlights
Throughout her career, Auvynet has worked with esteemed institutions such as Université Pierre et Marie Curie and Sorbonne Université. Her research has contributed to a deeper understanding of peptide interactions and their potential therapeutic benefits.
Collaborations
Auvynet has collaborated with notable colleagues, including Christophe Combadiere and Florian Sennlaub. These partnerships have enhanced her research and expanded the impact of her inventions.
Conclusion
Constance Auvynet is a trailblazer in the field of peptide research, with her innovative work on CCR2 antagonist peptides showcasing her expertise and dedication. Her contributions are likely to influence future developments in medical science.